<?xml version="1.0" encoding="UTF-8"?>
<EXPERIMENT_SET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <EXPERIMENT accession="SRX18479875" alias="Can_WT_apo_biol_rep1">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18479875</PRIMARY_ID>
      <SUBMITTER_ID namespace="SUB12342242">Can_WT_apo_biol_rep1</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>SHAPE-Seq performed on C. antarcticum</TITLE>
    <STUDY_REF accession="SRP411155">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP411155</PRIMARY_ID>
        <SUBMITTER_ID namespace="SUB12342242">bp0</SUBMITTER_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Modified RNA was extracted from live cells using a RiboPure Bacterial RNA Purification Kit (Invitrogen, AM1925) according to manufacturer's instructions. Modification of extracted RNA was analyzed using the SHAPE-seq v2.1 workflow (Watters, K.E. et al 2016) as described previously (Dutta, D. et al. 2020) with an additional purification step where samples were size selected to 160-300 bp using the 2% Agarose Gel on the PippinHT system (Sage Science,Beverly, MA). Each sample wasanalyzedwith SPATSversion 1.9.30</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15953280">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15953280</PRIMARY_ID>
          <SUBMITTER_ID namespace="pda|cameron_baker@urmc.rochester.edu">Sample_ReCo_Cba_WT_Apo_neg_VS_ReCo_Cba_WT_Apo_pos</SUBMITTER_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>Can_WT_apo_biol_rep1</LIBRARY_NAME>
        <LIBRARY_STRATEGY>RNA-Seq</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>TRANSCRIPTOMIC</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>cDNA</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <PAIRED/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <ILLUMINA>
        <INSTRUMENT_MODEL>Illumina MiSeq</INSTRUMENT_MODEL>
      </ILLUMINA>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18479876" alias="Can_WT_bound_biol_rep1">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18479876</PRIMARY_ID>
      <SUBMITTER_ID namespace="SUB12342242">Can_WT_bound_biol_rep1</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>SHAPE-Seq performed on C. antarcticum</TITLE>
    <STUDY_REF accession="SRP411155">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP411155</PRIMARY_ID>
        <SUBMITTER_ID namespace="SUB12342242">bp0</SUBMITTER_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Modified RNA was extracted from live cells using a RiboPure Bacterial RNA Purification Kit (Invitrogen, AM1925) according to manufacturer's instructions. Modification of extracted RNA was analyzed using the SHAPE-seq v2.1 workflow (Watters, K.E. et al 2016) as described previously (Dutta, D. et al. 2020) with an additional purification step where samples were size selected to 160-300 bp using the 2% Agarose Gel on the PippinHT system (Sage Science,Beverly, MA). Each sample wasanalyzedwith SPATSversion 1.9.30</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15953281">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15953281</PRIMARY_ID>
          <SUBMITTER_ID namespace="pda|cameron_baker@urmc.rochester.edu">Sample_ReCo_Cba_WT_60_neg_VS_ReCo_Cba_WT_60_pos</SUBMITTER_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>Can_WT_bound_biol_rep1</LIBRARY_NAME>
        <LIBRARY_STRATEGY>RNA-Seq</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>TRANSCRIPTOMIC</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>cDNA</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <PAIRED/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <ILLUMINA>
        <INSTRUMENT_MODEL>Illumina MiSeq</INSTRUMENT_MODEL>
      </ILLUMINA>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18479877" alias="Can_C31U_bound_biol_rep2">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18479877</PRIMARY_ID>
      <SUBMITTER_ID namespace="SUB12342242">Can_C31U_bound_biol_rep2</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>SHAPE-Seq performed on C. antarcticum</TITLE>
    <STUDY_REF accession="SRP411155">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP411155</PRIMARY_ID>
        <SUBMITTER_ID namespace="SUB12342242">bp0</SUBMITTER_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Modified RNA was extracted from live cells using a RiboPure Bacterial RNA Purification Kit (Invitrogen, AM1925) according to manufacturer's instructions. Modification of extracted RNA was analyzed using the SHAPE-seq v2.1 workflow (Watters, K.E. et al 2016) as described previously (Dutta, D. et al. 2020) with an additional purification step where samples were size selected to 160-300 bp using the 2% Agarose Gel on the PippinHT system (Sage Science,Beverly, MA). Each sample wasanalyzedwith SPATSversion 1.9.30</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15953282">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15953282</PRIMARY_ID>
          <SUBMITTER_ID namespace="pda|cameron_baker@urmc.rochester.edu">Sample_C31U_2_Bound_neg_VS_C31U_2_Bound_pos</SUBMITTER_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>Can_C31U_bound_biol_rep2</LIBRARY_NAME>
        <LIBRARY_STRATEGY>RNA-Seq</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>TRANSCRIPTOMIC</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>cDNA</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <PAIRED/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <ILLUMINA>
        <INSTRUMENT_MODEL>Illumina MiSeq</INSTRUMENT_MODEL>
      </ILLUMINA>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18479878" alias="Can_C31U_apo_biol_rep1">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18479878</PRIMARY_ID>
      <SUBMITTER_ID namespace="SUB12342242">Can_C31U_apo_biol_rep1</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>SHAPE-Seq performed on C. antarcticum</TITLE>
    <STUDY_REF accession="SRP411155">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP411155</PRIMARY_ID>
        <SUBMITTER_ID namespace="SUB12342242">bp0</SUBMITTER_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Modified RNA was extracted from live cells using a RiboPure Bacterial RNA Purification Kit (Invitrogen, AM1925) according to manufacturer's instructions. Modification of extracted RNA was analyzed using the SHAPE-seq v2.1 workflow (Watters, K.E. et al 2016) as described previously (Dutta, D. et al. 2020) with an additional purification step where samples were size selected to 160-300 bp using the 2% Agarose Gel on the PippinHT system (Sage Science,Beverly, MA). Each sample wasanalyzedwith SPATSversion 1.9.30</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15953283">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15953283</PRIMARY_ID>
          <SUBMITTER_ID namespace="pda|cameron_baker@urmc.rochester.edu">Sample_C31U_1_Apo_neg_VS_C31U_1_Apo_pos</SUBMITTER_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>Can_C31U_apo_biol_rep1</LIBRARY_NAME>
        <LIBRARY_STRATEGY>RNA-Seq</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>TRANSCRIPTOMIC</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>cDNA</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <PAIRED/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <ILLUMINA>
        <INSTRUMENT_MODEL>Illumina MiSeq</INSTRUMENT_MODEL>
      </ILLUMINA>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18479879" alias="Can_WT_apo_biol_rep2">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18479879</PRIMARY_ID>
      <SUBMITTER_ID namespace="SUB12342242">Can_WT_apo_biol_rep2</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>SHAPE-Seq performed on C. antarcticum</TITLE>
    <STUDY_REF accession="SRP411155">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP411155</PRIMARY_ID>
        <SUBMITTER_ID namespace="SUB12342242">bp0</SUBMITTER_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Modified RNA was extracted from live cells using a RiboPure Bacterial RNA Purification Kit (Invitrogen, AM1925) according to manufacturer's instructions. Modification of extracted RNA was analyzed using the SHAPE-seq v2.1 workflow (Watters, K.E. et al 2016) as described previously (Dutta, D. et al. 2020) with an additional purification step where samples were size selected to 160-300 bp using the 2% Agarose Gel on the PippinHT system (Sage Science,Beverly, MA). Each sample wasanalyzedwith SPATSversion 1.9.30</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15953284">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15953284</PRIMARY_ID>
          <SUBMITTER_ID namespace="pda|cameron_baker@urmc.rochester.edu">Sample_70_uM_1_Apo_neg_VS_70_uM_1_Apo_pos</SUBMITTER_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>Can_WT_apo_biol_rep2</LIBRARY_NAME>
        <LIBRARY_STRATEGY>RNA-Seq</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>TRANSCRIPTOMIC</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>cDNA</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <PAIRED/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <ILLUMINA>
        <INSTRUMENT_MODEL>Illumina MiSeq</INSTRUMENT_MODEL>
      </ILLUMINA>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18479880" alias="Can_WT_bound_biol_rep2">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18479880</PRIMARY_ID>
      <SUBMITTER_ID namespace="SUB12342242">Can_WT_bound_biol_rep2</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>SHAPE-Seq performed on C. antarcticum</TITLE>
    <STUDY_REF accession="SRP411155">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP411155</PRIMARY_ID>
        <SUBMITTER_ID namespace="SUB12342242">bp0</SUBMITTER_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Modified RNA was extracted from live cells using a RiboPure Bacterial RNA Purification Kit (Invitrogen, AM1925) according to manufacturer's instructions. Modification of extracted RNA was analyzed using the SHAPE-seq v2.1 workflow (Watters, K.E. et al 2016) as described previously (Dutta, D. et al. 2020) with an additional purification step where samples were size selected to 160-300 bp using the 2% Agarose Gel on the PippinHT system (Sage Science,Beverly, MA). Each sample wasanalyzedwith SPATSversion 1.9.30</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15953285">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15953285</PRIMARY_ID>
          <SUBMITTER_ID namespace="pda|cameron_baker@urmc.rochester.edu">Sample_70_uM_1_Bound_neg_VS_70_uM_1_bound_pos</SUBMITTER_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>Can_WT_bound_biol_rep2</LIBRARY_NAME>
        <LIBRARY_STRATEGY>RNA-Seq</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>TRANSCRIPTOMIC</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>cDNA</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <PAIRED/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <ILLUMINA>
        <INSTRUMENT_MODEL>Illumina MiSeq</INSTRUMENT_MODEL>
      </ILLUMINA>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18479881" alias="Can_C17U_apo_biol_rep1">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18479881</PRIMARY_ID>
      <SUBMITTER_ID namespace="SUB12342242">Can_C17U_apo_biol_rep1</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>SHAPE-Seq performed on C. antarcticum</TITLE>
    <STUDY_REF accession="SRP411155">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP411155</PRIMARY_ID>
        <SUBMITTER_ID namespace="SUB12342242">bp0</SUBMITTER_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Modified RNA was extracted from live cells using a RiboPure Bacterial RNA Purification Kit (Invitrogen, AM1925) according to manufacturer's instructions. Modification of extracted RNA was analyzed using the SHAPE-seq v2.1 workflow (Watters, K.E. et al 2016) as described previously (Dutta, D. et al. 2020) with an additional purification step where samples were size selected to 160-300 bp using the 2% Agarose Gel on the PippinHT system (Sage Science,Beverly, MA). Each sample wasanalyzedwith SPATSversion 1.9.30</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15953286">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15953286</PRIMARY_ID>
          <SUBMITTER_ID namespace="pda|cameron_baker@urmc.rochester.edu">Sample_C17U_1_Apo _neg_VS_C17U_1_Apo_pos_2</SUBMITTER_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>Can_C17U_apo_biol_rep1</LIBRARY_NAME>
        <LIBRARY_STRATEGY>RNA-Seq</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>TRANSCRIPTOMIC</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>cDNA</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <PAIRED/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <ILLUMINA>
        <INSTRUMENT_MODEL>Illumina MiSeq</INSTRUMENT_MODEL>
      </ILLUMINA>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18479882" alias="Can_C17U_bound_biol_rep1">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18479882</PRIMARY_ID>
      <SUBMITTER_ID namespace="SUB12342242">Can_C17U_bound_biol_rep1</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>SHAPE-Seq performed on C. antarcticum</TITLE>
    <STUDY_REF accession="SRP411155">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP411155</PRIMARY_ID>
        <SUBMITTER_ID namespace="SUB12342242">bp0</SUBMITTER_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Modified RNA was extracted from live cells using a RiboPure Bacterial RNA Purification Kit (Invitrogen, AM1925) according to manufacturer's instructions. Modification of extracted RNA was analyzed using the SHAPE-seq v2.1 workflow (Watters, K.E. et al 2016) as described previously (Dutta, D. et al. 2020) with an additional purification step where samples were size selected to 160-300 bp using the 2% Agarose Gel on the PippinHT system (Sage Science,Beverly, MA). Each sample wasanalyzedwith SPATSversion 1.9.30</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15953287">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15953287</PRIMARY_ID>
          <SUBMITTER_ID namespace="pda|cameron_baker@urmc.rochester.edu">Sample_C17U_1_Bound_neg_VS_C17U_1_Bound_pos_2</SUBMITTER_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>Can_C17U_bound_biol_rep1</LIBRARY_NAME>
        <LIBRARY_STRATEGY>RNA-Seq</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>TRANSCRIPTOMIC</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>cDNA</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <PAIRED/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <ILLUMINA>
        <INSTRUMENT_MODEL>Illumina MiSeq</INSTRUMENT_MODEL>
      </ILLUMINA>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18479883" alias="Can_C17U_apo_biol_rep2">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18479883</PRIMARY_ID>
      <SUBMITTER_ID namespace="SUB12342242">Can_C17U_apo_biol_rep2</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>SHAPE-Seq performed on C. antarcticum</TITLE>
    <STUDY_REF accession="SRP411155">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP411155</PRIMARY_ID>
        <SUBMITTER_ID namespace="SUB12342242">bp0</SUBMITTER_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Modified RNA was extracted from live cells using a RiboPure Bacterial RNA Purification Kit (Invitrogen, AM1925) according to manufacturer's instructions. Modification of extracted RNA was analyzed using the SHAPE-seq v2.1 workflow (Watters, K.E. et al 2016) as described previously (Dutta, D. et al. 2020) with an additional purification step where samples were size selected to 160-300 bp using the 2% Agarose Gel on the PippinHT system (Sage Science,Beverly, MA). Each sample wasanalyzedwith SPATSversion 1.9.30</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15953288">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15953288</PRIMARY_ID>
          <SUBMITTER_ID namespace="pda|cameron_baker@urmc.rochester.edu">Sample_C17U_2_Apo_neg_VS_C17U_2_Apo_pos</SUBMITTER_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>Can_C17U_apo_biol_rep2</LIBRARY_NAME>
        <LIBRARY_STRATEGY>RNA-Seq</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>TRANSCRIPTOMIC</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>cDNA</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <PAIRED/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <ILLUMINA>
        <INSTRUMENT_MODEL>Illumina MiSeq</INSTRUMENT_MODEL>
      </ILLUMINA>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18479884" alias="Can_C17U_bound_biol_rep2">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18479884</PRIMARY_ID>
      <SUBMITTER_ID namespace="SUB12342242">Can_C17U_bound_biol_rep2</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>SHAPE-Seq performed on C. antarcticum</TITLE>
    <STUDY_REF accession="SRP411155">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP411155</PRIMARY_ID>
        <SUBMITTER_ID namespace="SUB12342242">bp0</SUBMITTER_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Modified RNA was extracted from live cells using a RiboPure Bacterial RNA Purification Kit (Invitrogen, AM1925) according to manufacturer's instructions. Modification of extracted RNA was analyzed using the SHAPE-seq v2.1 workflow (Watters, K.E. et al 2016) as described previously (Dutta, D. et al. 2020) with an additional purification step where samples were size selected to 160-300 bp using the 2% Agarose Gel on the PippinHT system (Sage Science,Beverly, MA). Each sample wasanalyzedwith SPATSversion 1.9.30</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15953289">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15953289</PRIMARY_ID>
          <SUBMITTER_ID namespace="pda|cameron_baker@urmc.rochester.edu">Sample_C17U_2_Bound_neg_VS_C17U_2_Bound_pos</SUBMITTER_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>Can_C17U_bound_biol_rep2</LIBRARY_NAME>
        <LIBRARY_STRATEGY>RNA-Seq</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>TRANSCRIPTOMIC</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>cDNA</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <PAIRED/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <ILLUMINA>
        <INSTRUMENT_MODEL>Illumina MiSeq</INSTRUMENT_MODEL>
      </ILLUMINA>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18479885" alias="Can_C31U_bound_biol_rep1">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18479885</PRIMARY_ID>
      <SUBMITTER_ID namespace="SUB12342242">Can_C31U_bound_biol_rep1</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>SHAPE-Seq performed on C. antarcticum</TITLE>
    <STUDY_REF accession="SRP411155">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP411155</PRIMARY_ID>
        <SUBMITTER_ID namespace="SUB12342242">bp0</SUBMITTER_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Modified RNA was extracted from live cells using a RiboPure Bacterial RNA Purification Kit (Invitrogen, AM1925) according to manufacturer's instructions. Modification of extracted RNA was analyzed using the SHAPE-seq v2.1 workflow (Watters, K.E. et al 2016) as described previously (Dutta, D. et al. 2020) with an additional purification step where samples were size selected to 160-300 bp using the 2% Agarose Gel on the PippinHT system (Sage Science,Beverly, MA). Each sample wasanalyzedwith SPATSversion 1.9.30</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15953290">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15953290</PRIMARY_ID>
          <SUBMITTER_ID namespace="pda|cameron_baker@urmc.rochester.edu">Sample_C31U_1_Bound_neg_VS_C31U_1_Bound_pos</SUBMITTER_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>Can_C31U_bound_biol_rep1</LIBRARY_NAME>
        <LIBRARY_STRATEGY>RNA-Seq</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>TRANSCRIPTOMIC</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>cDNA</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <PAIRED/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <ILLUMINA>
        <INSTRUMENT_MODEL>Illumina MiSeq</INSTRUMENT_MODEL>
      </ILLUMINA>
    </PLATFORM>
  </EXPERIMENT>
  <EXPERIMENT accession="SRX18479886" alias="Can_C31U_apo_biol_rep2">
    <IDENTIFIERS>
      <PRIMARY_ID>SRX18479886</PRIMARY_ID>
      <SUBMITTER_ID namespace="SUB12342242">Can_C31U_apo_biol_rep2</SUBMITTER_ID>
    </IDENTIFIERS>
    <TITLE>SHAPE-Seq performed on C. antarcticum</TITLE>
    <STUDY_REF accession="SRP411155">
      <IDENTIFIERS>
        <PRIMARY_ID>SRP411155</PRIMARY_ID>
        <SUBMITTER_ID namespace="SUB12342242">bp0</SUBMITTER_ID>
      </IDENTIFIERS>
    </STUDY_REF>
    <DESIGN>
      <DESIGN_DESCRIPTION>Modified RNA was extracted from live cells using a RiboPure Bacterial RNA Purification Kit (Invitrogen, AM1925) according to manufacturer's instructions. Modification of extracted RNA was analyzed using the SHAPE-seq v2.1 workflow (Watters, K.E. et al 2016) as described previously (Dutta, D. et al. 2020) with an additional purification step where samples were size selected to 160-300 bp using the 2% Agarose Gel on the PippinHT system (Sage Science,Beverly, MA). Each sample wasanalyzedwith SPATSversion 1.9.30</DESIGN_DESCRIPTION>
      <SAMPLE_DESCRIPTOR accession="SRS15953291">
        <IDENTIFIERS>
          <PRIMARY_ID>SRS15953291</PRIMARY_ID>
          <SUBMITTER_ID namespace="pda|cameron_baker@urmc.rochester.edu">Sample_C31U_2_Apo_neg_VS_C31U_2_Apo_pos</SUBMITTER_ID>
        </IDENTIFIERS>
      </SAMPLE_DESCRIPTOR>
      <LIBRARY_DESCRIPTOR>
        <LIBRARY_NAME>Can_C31U_apo_biol_rep2</LIBRARY_NAME>
        <LIBRARY_STRATEGY>RNA-Seq</LIBRARY_STRATEGY>
        <LIBRARY_SOURCE>TRANSCRIPTOMIC</LIBRARY_SOURCE>
        <LIBRARY_SELECTION>cDNA</LIBRARY_SELECTION>
        <LIBRARY_LAYOUT>
          <PAIRED/>
        </LIBRARY_LAYOUT>
      </LIBRARY_DESCRIPTOR>
    </DESIGN>
    <PLATFORM>
      <ILLUMINA>
        <INSTRUMENT_MODEL>Illumina MiSeq</INSTRUMENT_MODEL>
      </ILLUMINA>
    </PLATFORM>
  </EXPERIMENT>
</EXPERIMENT_SET>
